GLIAL CELLS POINT WAY TO NEW THERAPIES FOR MSdistributed algorithmmultimedia synchronizationmobile multimediawireless communicationsAn abstract is unavailable.doi:10.1097/00132985-200505000-00009Charlene LainoNeurology Today
Hepatocellular carcinoma (HCC), one of the most common cancers worldwide, is often diagnosed at an advanced stage when most potentially curative therapies such as resection, transplantation or percutaneous and transarterial interventions are of limited efficacy. The fact that HCC is resistant to convent...
Manali Bhave, MD, discusses the impact of new treatment strategies on the landscape of hormone receptor–positive/HER2-negative breast cancer.
and is thinking about applying it with a second. He says ketamine could keep Ukrainians fighting more effectively and for longer. “The soldiers were surprised at being able to return to the front lines so quickly,” he says. “They simply didn't think it was possible.”...
Podcast: CAR T Cells and T-Cell Therapies for Cancer Editor's Note Translational Science Reviews—A New JAMA Review Mary M. McDermott, MD; Kristin L. Walter, MD, MS; Kirsten Bibbins-Domingo, PhD, MD, MAS JAMA Podcast: CAR T Cells and T-Cell Therapies for Cancer Editor's Note...
S1P signaling: New therapies and opportunities. F1000Prime Rep. 2014, 6, 109. [CrossRef] [PubMed]Gonzalez-Cabrera PJ, Brown S, Studer SM, Rosen H. S1P signaling: new therapies and opportunities. F1000Prime Rep. 2014;6:109. : 10.12703/P6-109 . Central...
to that with conventionaltherapies. Several issues arestill of concern, however. These issuesinclude the possible link betweeninhaled insulin and adverse pulmonaryeffects, insulin antibody formation,and variability of absorptionin smokers and in those with pulmonarydisease. The promise ofinhaled insulin is...
"It is wonderful for providers and patients to have these opportunities, but new challenges have emerged on how to best sequence these therapies, combine these therapies, and how to manage patients who fail all of these therapies either sequentially or in combination."Treatment for patients with...
(Figs.2and3). However, an increasing number of early-phase trials of therapies for symptoms, including cognitive enhancers and agents for relieving BPSD, are being conducted. This reflects the unmet clinical need for such therapies (Figs.2and3). Similarly, an increasing number of phase 1 ...
If psychedelic therapies do prove to have enduring effects after just a single or a few administrations in the context of a few sessions for preparation and integration, they have the potential to offer not just a new approach to mental health care, but an entirely new paradigm of care. ...